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 ABSTRACT 
 
Human Papillomavirus (HPV) Vaccine: Understanding Individuals Not Vaccinating in the South 
Using 2016 National Immunization Survey-Teen Data (NIS-Teen) 
 
By 
 
Saron Ephraim  
 
May 1, 2018 
 
INTRODUCTION:  Human Papilloma Virus (HPV) is a highly contagious virus known to cause 
many cancers in men and women. Vaccination for HPV has been available since 2006 but 
coverage levels remain low with initiation rates at 60% and only 43% completion. The lowest 
vaccination rates are found in the South.  
 
AIM:  This study aims to use data from the 2016 National Immunization Survey –Teen to 
evaluate parental reasons for not vaccinating their teen for HPV among respondents in the 
South. The study evaluated the demographic correlations of the top four reasons reported for 
not vaccinating against HPV.   
 
METHODS: Mantel-Haenszel χ2 test was done to assess possible differences for individuals 
initiating HPV vaccination and those who had not by sociodemographic factors. Logistic 
regression done evaluated several sociodemographic factors for top reasons for not 
vaccinating. Analysis of the data was done using Statistical Analysis Systems 9.4.    
 
RESULTS:  The top four reasons given for not vaccinating for HPV were: 1) vaccine is not 
needed/not necessary; 2) vaccine was not recommended; 3) concerns about vaccine 
safety/side effects and 4) lack of knowledge about vaccine. Mother’s education, mother’s age, 
race of teen, and gender were significantly associated with the top four reasons.  
 
DISCUSSION: The results of this study imply specific sociodemographic factors are associated 
with the top four reasons for declining HPV vaccine. Highly educated mothers were significantly 
associated with the top four reasons for declining vaccine.  
 
Keywords: Human Papilloma Virus (HPV), vaccination rates, southern states, not vaccinating for 
HPV, HPV vaccine safety concerns/side effects    
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 Introduction  
1.1 Background  
 
Human Papilloma Virus (HPV) vaccination rates remain well below the 2020 Healthy 
People goal of 80% in the United States. National coverage data from 2016 found that 60.4% 
(65.1% of females; 56% of males) of teens had initiated the HPV series and only 43.4% (49.5% of 
females; 37.5% of males) had completed all recommended doses (Walker et al., 2017). 
Although the HPV vaccine has been around for over a decade, vaccine uptake remains low.  The 
South, as a region, had some of the lowest HPV vaccination rates in 2011 with 48.4% initiation 
and 30.6% completion (Rahman, McGrath, & Berenson, 2014).  National data shows that the 
lowest HPV vaccine initiation and completion rates are in southern states with 47.8% initiation 
in Mississippi and 30.8% completion in South Carolina (Walker et al., 2017). It has been well 
established that HPV is a virus that causes many types of genital and oral cancers. There are an 
estimated 19,400 women and 12,100 men who are affected by cancers cause by HPV annually 
in the United States (Centers for Disease Control and Prevention [CDC], 2017). HPV infection is 
responsible for 99.8% of cervical cancer and 90% of genital warts and cancer of the anogenital, 
head and neck regions (Rahman et al., 2014).  HPV is a very common virus and approximately 
79 million Americans are currently infected with HPV and about 14 million new cases of HPV 
infections occur each year (CDC, 2017).  
The Food and Drug Administration (FDA) first licensed a vaccine in 2006 for use in 
females age 9 through 26 ("FDA Licensure of Bivalent Human Papillomavirus Vaccine”, 2010) 
and the Advisory Committee on Immunization Practices (ACIP) made a routine 
recommendation for HPV vaccination for girls 11 to 12 years of age (up to age 26). In 2011 that 
 recommendation was extended to include boys up to age 21 (Seyferth, Bratic, & Bocchini, 
2016). Low vaccine coverage is a public health concern because HPV is very common. Every 
adult will eventually acquire HPV, even if it is a latent infection, at least once in their lifetime. 
Previous research has found some trends in the possible explanation for the low uptake in HPV 
vaccine. Many studies have shown that having a strong provider recommendation helps 
improve vaccine initiation for HPV vaccine and that low uptake of HPV vaccine is due to a lack 
of physician recommendation (Mohammed, Vivian, Loux, & Arnold, 2017). In addition, concerns 
about safety and insufficient knowledge of HPV have been cited as sources for low uptake 
(Mohammed et al., 2017). Other studies have suggested that completion is a challenge for this 
vaccine despite having provider recommendation (Luque, Tarasenko, Dixon, Vogel, & Tedders, 
2014). The rise in vaccine hesitant parents and parents who are electing to delay vaccinating 
their children have also been offered up as an explanation for low uptake. Existing studies 
looking at the low vaccine uptake have tried to understand why parents are choosing not to 
vaccinate their children for HPV.  Once the factors for refusing HPV vaccines are properly 
understood, appropriate public health interventions can be implemented to improve health 
outcomes. In the same effort, this study also aims to better understand the reasons provided by 
parents for not vaccinating their teens for HPV in the South.  
1.2 Purpose & Research Questions 
 
The purpose of this study is to evaluate the main reasons for not vaccinating for HPV 
within the 17 southern states using the 2016 National Immunization Survey –Teen data. 
Because the South has the lowest initiation and completion rates for HPV vaccine, it is 
 beneficial to understand the nuances for the reasons given for not vaccinating among 
individuals who are not vaccinating for HPV. The main research questions for this paper are: 
1) What are the most common reasons provided for not vaccinating for HPV in the 17 
southern states?  
2) What are some of the sociodemographic factors that correlate with the top reasons 
for not vaccinating?  
3) Is there a relationship between gender, race, mother’s age, number of children 
under 18 in the household, mother’s education and the reasons provided for not 
vaccinating for HPV?   
Based on existing research, the expected outcome is that the top reasons for not vaccinating 
for HPV in the South will resemble the reasons provided at the national level.  Older mothers 
and those with higher education levels will be associated with the top reasons identified for 
declining HPV vaccination. There may be additional variations in how demographic 
characteristics correlate with the responses given for not vaccinating for HPV. Once the reasons 
for declining HPV vaccination are better understood, more focused interventions can be 
implemented to address concerns about HPV vaccine in the South. 
Literature Review 
2.1 Vaccine Coverage  
 
In 2016, only 43.4% of adolescents (49.5% of females and 37.5% of males) between the 
ages of 13 to 17 were up to date with their HPV vaccination series. These numbers were higher 
for adolescents who had one or more doses of HPV, 61.1% for females and 56% for males 
(Walker et al., 2017). Improvements in HPV coverage levels have been occurring but they have 
 been very gradual. In 2014, the initiation rate for HPV vaccine was 60% for females and 41.7% 
for males (Reagan-Steiner et al., 2015). Between 2011 and 2012 there was no progress for 
national HPV vaccination coverage rates for females ages 13 to 17 and a 3.3 percentage point 
increase in 2014 (Reagan-Steiner et al., 2015).  From 2015 to 2016 HPV vaccination initiation 
rates and completion rates went up 4.3 percentage points and 2.2 percentage points 
respectively (Walker et al., 2017). Other vaccines routinely administered for the same age range 
as the HPV vaccine, Tdap and Meningococcal (MenACWY), both have higher vaccination rates 
than HPV with 88% and 82.2% respectively (Walker et al., 2017). In general, other vaccines 
routinely administered in the United States have had higher acceptance and completion rates; 
most of these vaccine rates have reached or exceeded the 2020 Healthy People goals. Vaccine 
initiation for HPV continues to slowly increase but remains 22 to 28 % points lower than those 
for Tdap and ≥1 -dose MenACWY (Walker et al., 2017).  
There are differences in coverage levels observed in different subgroups and geographic 
regions for HPV vaccine. 2012 data showed that initiation rates for those that are older (19 to 
26 years of age) were only 34.5% for females and 2.3% for males (Rahman, Islam, & Berenson, 
2015). A study conducted by Rahman, Islam, and Berenson in 2015 found that HPV vaccination 
rates did not differ by region for men but they did for women and the lowest rates of initiation 
for women 19 to 26 were found in the South. Another study conducted by Rahman, McGarth, 
and Berenson (2014) found similar trends for girls 13 to 17 years old with the lowest HPV 
initiation and completion rates found in the South, 48.4% and 30.6% respectively. These low 
coverage levels for HPV vaccination in the South signal a need to further understand the 
reasons for the low uptake in this region of the country.  
 Race and income were found to be influential in initiation and completion rates among 
boys. The odds were higher for initiating and completing HPV vaccines for boys who were on 
Medicaid/SCHIP, boys who received a provider recommendation, boys from households with 
incomes below the poverty threshold, boys who were Hispanic and boys who were Non-
Hispanic Black (Henry, Swiecki-Sikora, Stroup, Warner, & Kepka, 2017). A study conducted by 
Henry et al. (2017) found that the lowest initiation rates for HPV vaccination among boys were 
in more affluent areas regardless of race/ethnicity. These disparities in HPV vaccination 
initiation rates highlight potential targets for interventions aimed at improving vaccination 
rates.  
2.2 HPV Vaccination is Cancer Prevention   
 
In the US, all cervical cancer and anal cancers in the population are attributable to HPV 
infections (Seyferth et al., 2016). HPV infection causes most anogenital cancers as well as 
oropharyngeal cancers which contributes to an estimated 600,000 cancer occurrences 
worldwide and 250,000 premature deaths (Saraiya et al., 2015).  There are currently three 
different HPV vaccines licensed and available for use in the United States: the 4-valent HPV 
vaccine which was first licensed in 2006 for use in women and in 2009 for use in men; the 2-
valent HPV vaccine licensed for use in only women in 2009; the 9-valent HPV vaccine which was 
licensed in 2014 for use in both women and men (Seyferth et al., 2016). The ACIP has 
recommended that adolescents between 11 to 12 years of age routinely receive HPV vaccine 
and females 13 to 26 years and males 13 to 21 years who had not been previously vaccinated 
receive vaccination for HPV (Petrosky et al., 2015).  In 2016 the recommendation changed from 
 a three-dose series to a two-dose series depending on when the vaccine was first initiated 
(Walker et al., 2017).  
HPV vaccine has been shown to be effective and has contributed to reductions in the 
prevalence of HPV. A study comparing pre- and post-vaccine era prevalence of HPV strains 
found in the vaccine noted that there was a 56% decrease in prevalence among 14 to 19-year-
old females (Markowitz et al., 2013). Not only has the vaccine been shown to help reduce the 
prevalence of HPV included in the vaccine, it has also produced the appropriate immune 
response among those vaccinated. A study conducted by Joura et al. (2015) demonstrated that 
nearly 100% of women 16 to 26 years of age vaccinated with 9-valent HPV vaccine developed 
antibodies of all the included strains in the vaccine within the first month after completing the 
3-dose series. There are an estimated 31,500 newly diagnosed cancers in men and women 
attributable to HPV and approximately 90% of these could be prevented with the receipt of the 
9-valent HPV vaccine (Walker et al., 2017, p.881).  In addition, the beneficial effects at the 
population level for HPV vaccination can be observed as early as 3 years after the introduction 
of an HPV vaccination program (Joura et al., 2015). The benefits of implementing an HPV 
vaccination program and improving coverage levels help prevent cancer at the individual as 
well as improve population health in a short timeframe.  
2.3 Provider Recommendation  
 
Many studies demonstrate the fundamental role provider recommendations have with 
HPV vaccine initiation rates. In a study conducted by Mohammed et al. (2016) parents cited 
that the main reason for not vaccinating their boys for HPV was the lack of a strong 
recommendation from the provider. There have been many efforts to improve provider 
 recommendation of the HPV vaccination to patients but rates remain low. Mohammed et al. 
(2017) used National Immunization Teen Survey data from 2014 and found that overall 72.6% 
of girls and 51.8% of boys received a provider recommendation of HPV vaccination. Provider 
recommendation is one of the most important predictors of HPV vaccine uptake among 
adolescents and if patients are not receiving recommendations the likely outcome will be low 
vaccine utilization.  
There is also evidence showing that among parents of teen girls surveyed only 29% were 
given HPV recommendations that aligned with current national guidelines (Lindley et al., 2016). 
This implies that despite providers’ making recommendations, few may be making the 
recommendation in line with the ACIP guidelines. The deviation from the national guidelines for 
HPV vaccination leads to variation in who is receiving a recommendation. Girls have a 2.57 
higher odds of receiving provider recommendations for HPV vaccines than boys, which points 
to the bias associated with lower recommendation for boys (Mohammed et al., 2016).  
Variations in the way providers make recommendations have also been observed for 
different racial and ethnic groups. A study conducted by Burdette, Webb, Hill, & Jokinen-
Gordon (2017) found that provider recommendations among males and females varied by race 
and ethnicity. Approximately 52% of African American females received a recommendation 
compared to 61% among non-Hispanic White females (Burdette, Webb, Hill, & Jokinen-Gordon, 
2017). This study also found that race and ethnic disparities in HPV vaccination rates among 
males are heavily influenced by differences in provider recommendations. For females, 
minority girls have seen a higher increase in provider recommendations and HPV vaccination 
uptake compared to non-Hispanic Whites (Burdette et al., 2017). Luque, Tarasenko, Dixon, 
 Vogel, & Tedders (2014) showed that only “46% of Georgia Vaccines for Children (VFC) 
providers who saw 11 to 12-year-old female patients, always made a recommendation for HPV 
vaccination. Similarly, Texas had 48% of the physicians reporting that they had always 
recommended HPV vaccination for female patients between 11 to 12 years old (Tarasenko, 
Dixon, Vogel, & Tedders, 2014).   
Other researchers have found similar variations in the rate of vaccine recommendations 
made by providers based on the teen’s demographic factors. Among boys, the lowest vaccine 
recommendation rates were found for those living in the South (43.7%), those living below the 
poverty line (49.4%), and for those with mothers having less than a high school education 
(44.8%) (Mohammed et al., 2016). The lowest recommendation rates for females were 
observed among Hispanics (69.2%), living in the South (69.1%), those living below the poverty 
line (64.9%), and those with mothers whose education level was less than high school 
education (61.9%) (Mohammed et al., 2016). Since provider recommendation is an important 
factor in the uptake of HPV vaccines these variations in recommendation can contribute to the 
variation in uptake among different subgroups. Adolescent boys and girl living in the South had 
lower odds of vaccine recommendation compared to those living in the Northeast, Midwest, 
and West (Mohammed et al., 2016). Vaccination coverage for females with ≥1-dose of HPV was 
lowest in Mississippi with 47.9% and up-to-date estimates for females was lowest in South 
Carolina with 30.8% (Walker et al., 2017). The literature suggests that those residing in the 
South are receiving recommendations for HPV at lower rates which may be influencing the 
trend in low HPV vaccination initiation and completion in this region. 
 In addition to the importance of the provider’s recommendation, the providers’ vaccine-
related attitudes are also strongly associated with the parents’ attitudes about vaccinations 
(Mergler et al., 2013). A study conducted by Salmon et al. (2008) found that most Primary 
Health Care Providers (PHCPs) identified by children exempt from school immunization 
requirements and those children without school immunization exemptions had similar attitudes 
concerning vaccinations. There was a striking difference found between PHCP of children with 
vaccine exemptions regarding immunization safety beliefs. The study findings show that the 
knowledge, attitudes, and practices of PHCPs may be a contributing factor on the parent’s 
decisions to decline or accept vaccinations (Salmon et al., 2008).  Mergler et al. (2013) also 
found that guardians had 45 times higher odds of agreeing that there were community benefits 
to having children fully vaccinated when their provider agreed, compared to guardians whose 
providers did not agree. The acceptance of vaccines by parents is not simply based on provider 
recommendation but also related to the providers attitude about vaccinations.  
2.4 Who’s Refusing to Vaccinate & Why?  
 
A study conducted by Cheruvu, Bhatta, and Drinkard (2017) looked at those who had no 
intentions to vaccinate for HPV over several study periods using NIS-Teen data and found very 
distinct characteristics for those not vaccinating. Parents in the survey years 2009 to 2012 were 
significantly more likely to report ‘no intent’ to vaccinate for HPV and cite safety and 
effectiveness concerns as their reason for not vaccinating for HPV compared to parents 
surveyed in 2008 (Cheruvu, Bhatta, & Drinkard, 2017). This study also found that, for 
unvaccinated females, three out of five parents reported that they had no intentions to 
vaccinate their daughters in the next 12 months. There were also some sociodemographic 
 factors associated with the parents’ intention to not vaccinate for HPV. Factors associated with 
parents’ decision to not vaccinate their daughters included: the number of people in the 
household, annual household income of $35,001 - $75,000, mothers with higher than high 
school education, and mother’s over 45 years of age (Cheruvu et al., 2017). A similar study that 
looked at parents’ intent to vaccinate for HPV found that for parents of US adolescents (13 to 
17), maternal education was the strongest predictor of intent to obtain HPV vaccination for 
their teen (Mohammed et al., 2017). Among parents of adolescent boys, mother’s marital 
status, and non-Hispanic black race/ethnicity were significant predicators of intention to obtain 
HPV vaccination (Mohammed et al., 2017).   
Similar trends were found among those initiating the HPV vaccination series. For boys, 
racial/ethnic minorities and those in the VFC program had higher rates of initiation whereas 
boys with highly educated mothers were less likely to be fully immunized (Johnson, Lin, Cabral, 
Kazis, & Katz, 2016). Using data form NIS-Teen a study conducted by Johnson et al. (2016) 
revealed several reasons parents provided for refusing to vaccinate their teens for HPV: vaccine 
was not recommended, vaccine was not needed, lack of knowledge, safety concerns, and the 
teen was not sexually active. There were also differences in reasons for vaccine refusal based 
on the gender of the child. Parents/guardians of male children were significantly more likely to 
indicated that the vaccine was not recommended by the provider and that the vaccine was not 
necessary; whereas parents/guardians of girls were significantly more likely to report concerns 
for vaccine safety (Johnson et al., 2016). Challenging the results of previously cited studies, this 
study also found that provider recommendation was not associated with completion of the 
three-dose series indicating that although provider recommendation is important there may be 
 other factors associated with completion of the series (Johnson et al., 2016). There were also 
some characteristics that made individuals immune to provider recommendations. Even though 
providers were more likely to recommend the vaccine to girls who had mothers with higher 
education levels, these mothers were immune to the recommendations from the provider 
(Johnson et al., 2016). Provider recommendation may be important but there are other factors 
that influence the decision of caregivers to get the HPV vaccine for their teen.  
Thompson, Rosen, Vamos, Kadono, & Daley (2017) conducted an analysis of NIS-Teen 
data from 2012 to 2015 to evaluate the reasons provided for not vaccinating for HPV and found 
that the most common reason for non-vaccination among males was lack of recommendation 
in years 2012 and 2013. However, in 2014 and 2015 the most common reason was that the 
vaccine was not needed. For females, the most common reason for not vaccinating was that 
the vaccine was not needed for all survey years. These studies demonstrate that there is still a 
gap in knowledge among parents about the importance and need for HPV vaccination.  
2.5 Vaccine Hesitancy  
 
 Vaccine hesitancy has been around since vaccines were first developed and individual 
hesitancy to vaccinate has been an ongoing concern for the healthcare community (Patel & 
Berenson, 2013; Siddiqui, Salmon, & Omer, 2013). The success of vaccine programs have led to 
a shift in fear from vaccine-preventable diseases to the fear of the vaccines that prevent those 
diseases (Siddiqui et al., 2013). Many who are electing to not vaccinate tend to be older 
mothers (≥30 years old), college educated and tend to be living in higher income households 
(Siddiqui et al., 2013). Vaccine Hesitant Parents (VHP) believe that children receive too many 
vaccines, that their child may have serious side effects from vaccines, and that vaccines may 
 negatively impact their child’s immune system (Williams, 2014). Most barriers to vaccinate for 
VHP are centered around concerns about vaccine safety (Williams, 2014). Results from studies 
evaluating the demographic information of parents who tend to refuse vaccines revealed that 
parents who refuse tend to be more educated whereas those who accept vaccination have a 
lower education level (Patel & Berenson, 2013). 
 The literature suggests that the low uptake of HPV vaccine is also connected to safety 
concerns, and inadequate knowledge about HPV (Mohammed et al., 2017). National 
Immunization Survey from 2003 found that 21.8% of parents intentionally delayed vaccine 
doses and that these parents reported vaccine safety concerns as reasons for the delay 
(Salmon, Dudley, Glanz, & Omer, 2015). A systematic literature review conducted by Holman et 
al. in 2014 found that parents were aware of the HPV vaccine but expressed the need for more 
information before they decided to vaccinate their children and cited lack of knowledge as a 
barrier (Holman et al., 2014). Holman et al. (2014) also found that parents reported having 
concerns about adverse effects and vaccine safety which were hinderance for vaccine uptake.  
 A focus group conducted by Sanders Thompson, Arnold, and Notaro (2012) of African 
American parents also uncovered similar findings of the need for more education on HPV 
vaccinations and the reasons that HPV vaccination is recommended at younger ages.  The semi-
structured interview of 30 participants was conducted after initial interviews involving two 
hundred African American men and women about their attitudes towards HPV vaccination. 
There were six major themes identified as influencing parental decisions about HPV vaccination 
and those included: the influence of physician recommendation, vaccine decision making, 
desire for information related to vaccine safety, youth sexuality, HPV vaccine costs, and 
 religious issues affecting HPV vaccination decisions (Sanders Thompson et al., 2012). The 
researchers found that although this group was religious, religion did not appear to be a barrier 
to HPV vaccination and these parents were not concerned that HPV vaccination would lead to 
early sexual activity (Sanders Thompson et al., 2012). The findings by Sanders Thompson et al. 
did show that there were concerns about vaccine safety, cost, and age of vaccination. Despite 
the concerns there was a desire to receive more information on these topics. Another 
important finding to note from this study was the suggestion that parents were not aware of 
the reasons for the targeted ages for HPV vaccination which aligned with previous studies. If 
parents are not clear on the need to vaccinate adolescents 11 to 12 years for HPV then they will 
decline the vaccine on the basis that it is not needed or necessary (Sanders Thompson et al., 
2012). It is important to understand the perceptions parents have of HPV vaccination, their 
concerns, and gaps in knowledge; this will inform tailored interventions to improve vaccine 
uptake and sufficiently address parents’ concerns.  
In addition to concerns about safety, attitudes about HPV vaccination and actual choices 
about vaccinating for HPV can be conflicting. A United States national assessment of parental 
attitudes about male HPV vaccination found that 90% of parents agreed that male HPV 
vaccination was generally but only about half of parents of boys planned to have their own sons 
vaccinated against HPV as adolescents (Dempsey, Butchart, Singer, Clark, & Davis, 2011). 
Although parents perceived HPV vaccination as a good thing there was a disconnect when it 
came time to vaccinating their own child. This disconnect demonstrates the potential 
breakdown in public health messaging about HPV and the way parents receive these messages.     
  In 2009, the Association of State and Territorial Health Offices (ASTHO) commissioned a 
survey to collect information about effective messages and materials to address parental 
concerns about vaccinations. The results of the survey showed that a strong majority of parents 
supported vaccinations but had concerns about their safety and possible adverse effects 
(Association of State and Territorial Health Offices [ASTHO], 2010). The survey also evaluated 
vaccine acceptance and found that 16% of parents had refused vaccine for their children.  Of 
those refusing vaccines 6% are considered “minor refusers” who decline Hep A, HPV, or flu 
vaccines; 10% are considered “significant refusers” who refuse one or more routinely 
recommended childhood vaccines (ASTHO, 2010). Another 5% of parents and guardians have 
major concerns about vaccinating their children yet they have not refused a vaccine (ASTHO, 
2010). The survey found that the most frequently refused vaccine was HPV. The findings of the 
ASTHO commissioned survey demonstrate the persistent concerns from parents about 
vaccines, even among those who choose to vaccinate.  
2.6 Policy Interventions  
 
 49.8% of adolescent males and 62.8% of females had one or more doses of HPV vaccine 
in 2015 but 81.3% had received Tdap and 87.1% had received meningococcal conjugate (MVC4) 
vaccine (Thompson, Rosen, Vamos, Kadono, & Daley, 2017, p. 289). These numbers suggest 
that HPV vaccination rates continue to linger behind those of Tdap and MCV4 indicating that 
there is something specifically unique about the perceptions of HPV vaccination that is leading 
to the slow uptake. Due to this finding, many states have attempted to pass legislative and 
policy level interventions with the attempt to increase uptake.  A study conducted by Perkins, 
Lin, Wallington, and Hanchate (2016) used NIS-Teen data for survey years 2009 to 2013 
 evaluated vaccination rates among girls residing in states and jurisdictions with school-entry 
mandates for HPV and those in states with educational mandates. The study found that laws 
passed to improve HPV vaccination rates did not result in higher vaccine coverage in states and 
jurisdictions with mandates compared to those without (Perkins, Lin, Wallington, & Hanchate, 
2016). It concluded that before considering legislation, policies should focus on getting 
providers to give strong, consistent recommendations to prevent skepticism and hesitancy 
among parents (Perkins, Lin, Wallington, & Hanchate, 2016).  
 Another study by Sadaf, Richards, Glanz, Salmon, and Omer (2013) conducted a 
systematic review of interventions to reduce vaccine refusal and hesitancy. The findings from 
this study did not reveal any evidence on effective interventions to address parental vaccine 
hesitancy and refusal. Sadaf et al. (2013) discussed the need to develop interventions that can 
influence parents’ perceptions about vaccines and the need for research focused on changing 
behavior. As vaccine refusals grows, policy makers should seek interventions that can improve 
vaccination rate among parents who normally refuse vaccinations (Sadaf, Richards, Glanz, 
Salmon & Omar, 2013). The need to address the concerns of parents who are hesitant about 
vaccinating for HPV is imperative in order to improve vaccine coverage in the United States. 
Increasing HPV vaccination coverage will help reduce the burden of disease caused by HPV.  
 Vaccine recommendation, although important, is not being given consistently. HPV 
vaccination rates continue to fall behind other adolescent vaccination rates. The lowest 
initiation and completion rates for HPV vaccine are found in the South. And mothers that are 
older, white, with college education, and more affluent tend to be the ones not vaccinating. 
Concerns about vaccine safety, not understand why HPV vaccine is administered between 11 to 
 12 years, and a general lack of awareness of how the immune system works in conjunction with 
vaccines have led to the low uptake in HPV vaccination. Fully understanding similar possible 
trends in the South will help improve education efforts aimed at improving vaccination 
coverage levels for HPV.  
Methods & Procedures  
3.1 National Immunization Survey –Teen 2016 (NIS-Teen) 
 
 NIS-Teen is an annual survey conducted by the National Center for Immunization and 
Respiratory Diseases and the National Center for Health Statistics of the Centers for Disease 
Control and Prevention. NIS-Teen uses a two-phase method of collecting a large national 
probability sample of teens aged 13 to 17 years of age. The sample includes households in the 
50 states, the District of Columbia, and the U.S. Virgin Islands. The first phase involved a 
random digit dialing (RDD) telephone (landline and cell phone numbers) survey to identify 
households with age-appropriate teens. Once a household was identified the adult with the 
most knowledge about the teen’s immunization history was interviewed. In the second phase 
providers identified as having administered vaccinations to the teen were mailed surveys to 
collect information about the immunization history of the teen. The 2016 dataset had a total of 
41,994 completed household interviews. Detailed methods for sampling for the NIS-Teen 2016 
are available for review (National Center for Immunization and Respiratory Diseases, 2017). 
NIS-Teen 2016 was deidentified and made available for use as a public dataset.  
3.2 Sample   
 
 This study used a subset sample (n=16,125) of all respondents residing in the 17 states 
that are part of the South region as defined by the United States Census Bureau. The 17 states 
 are Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, 
Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, 
and West Virginia (U.S. Census Bureau, n.d.). From the 16,125 respondents in the south, 
another subset was taken from the data for those who had a “yes” or “no” response to the 
question asking if the teen had any doses of HPV vaccine (n=14460). Only the household survey 
portion of NIS-Teens was used for this study.  
3.3 Reasons for not Vaccinating for HPV 
 
 Respondents of the household survey were asked several questions about HPV 
vaccination in relation to the selected teen. The parent or guardian was asked “has the teen 
ever received HPV shots?” and parents could respond yes, no, or don’t know. Those who 
responded with a “no” were asked a follow up question about their intentions to have the teen 
vaccinated. The question asked, “how likely is it that the teen will receive HPV shots in the next 
12 months?”. Parents who responded, “very likely” or “somewhat likely” were considered to 
have intentions to vaccinate their teen. Those who responded, “not too likely”, “not likely at 
all”, or “not sure/don’t know” were considered to be parents who had no intention to vaccinate 
their teen for HPV vaccine. These parents were asked follow-up questions about the main 
reasons for choosing not to vaccinate in the next 12 months. Respondents had an option to 
select the main reason from 14 possible options. If the parent provided more than one reason 
they were asked “what would you say is the MAIN reason?”. For the analysis, the following 
reasons were selected to be evaluated for the subgroup that was defined as having no intention 
to vaccinate for HPV: 
 
• vaccine was not recommended 
• not needed/not necessary 
• don’t believe in immunizations 
• lack of knowledge 
• [teen] not sexually active 
• not appropriate age 
• safety concerns/side effects 
• religion/orthodox 
• more info/new vaccine 
• not a school requirement 
• increased sexual activity concerns 
• child is male  
3.4 Statistical Analysis 
 
 The sample size (n=14460) consisted of those who responded “yes” or “no” to the 
question that asked, “has the teen received HPV shots?”.  A univariate analysis was conducted 
to test for differences between those who responded “yes” or “no” to the question by 
sociodemographic factors (age of teen, gender of teen, relationship of respondent to teen, 
mother’s age, mother’s education level, marital status of mother, housing, poverty status and 
the number of children under 18 in the household). The sociodemographic factors were 
selected based on what was available in the household survey and based on what was found in 
the literature for factors associated with declining HPV vaccination. A similar univariate analysis 
was done to test the relationship between respondents that answered “yes” or “no” and the 
states in which they resided. These tests were used to determine if there were difference 
among those who started vaccinating for HPV and those who did not by different 
sociodemographic factors. The p-values were calculated with 95% confidence intervals and 
statistical significance was defined as a p-value of < 0.05.  
Frequencies were calculated for the 12 main reasons provided for not vaccinating for 
HPV among respondents who were defined as having no intention to vaccinate. Those who 
answered “yes” or “no” to the 12 reasons were included in calculations for the frequencies 
 (n=5824). The top four reasons provided were identified and further frequency distributions 
were evaluated for these top four reasons and sociodemographic factors including the gender 
of the teen, mother’s age, relationship of respondent to teen, and the number of teens under 
18 in the household.  
A logistic regression analysis was performed for each of the top four reasons given for 
not vaccinating for HPV. The dependent variable was the response of “yes” to the reason for 
not vaccinating for HPV; meaning the respondent agreed that the reason selected was the main 
reason for electing not to vaccinate their teen for HPV in the next 12 months. The following 
independent factors were included in the model the gender of teen, mother’s age, mother’s 
education level, the number of children under 18 in household, race/ethnicity, and the 
relationship of respondent to the teen. These factors were included in the model because of 
existing evidence in the literature that showed connections with these factors and intention to 
vaccinate for HPV.  The model was tested four different times for the top four different reasons 
for not vaccinating.  All analysis was done using Statistical Analysis Systems 9.4. 
Results  
4.1 Sample Characteristics  
 
  Table 1 has the distribution of HPV vaccination status for teens 13 to 17 among the 
southern states included in this study. Statistical significance was found between those 
answering “yes” or “no” to having a dose of HPV and the state of residence of the teen. This 
indicates that there is a difference between those who had started their HPV vaccination and 
those who had not started by state of residence. 
 
 Table 1: HPV Vaccination Status by State of Residence  
*True State of Residence of 
Teen 
n=14460 
# (%) 
HPV Dose 
Yes (%) 
HPV Dose 
No (%) 
Alabama 608 (4.2) 283 (46.6) 325 (53.5) 
Arkansas 638 (4.4) 290 (45.4) 348 (54.6) 
Delaware 677 (4.7) 392 (57.9) 285 (42.1) 
District of Columbia 725 (5.0) 505 (69.7) 220 (30.3) 
Florida 764 (5.3) 381 (49.9) 383 (50.1) 
Georgia 679 (4.7) 357 (52.6) 322 (47.4) 
Kentucky 578 (4.0) 262 (45.3) 316 (54.7) 
Louisiana 626 (4.3) 300 (47.9) 326 (52.1) 
Maryland 843 (5.8) 535 (63.5) 308 (36.5) 
Mississippi 618 (4.3) 250 (40.5) 368 (59.6) 
North Carolina 695 (4.8) 357 (51.4) 338 (48.6) 
Oklahoma 581 (4.0) 268 (46.1) 313 (53.9) 
South Carolina 629 (4.4) 283 (45.0) 346 (55.0) 
Tennessee 550 (3.8) 261 (47.5) 289 (52.6) 
Texas 3822 (26.4) 1853 (48.5) 1969 (51.5) 
Virginia 826 (5.7) 456 (55.2) 370 (44.8) 
West Virginia 601 (4.2) 318 (52.9) 283 (47.1) 
* State FIPS Code used. 
Mantel-Haenszel Chi-square test was used to calculate p-values using 95 % confidence interval (CI) for the difference between those answering yes or no to having HPV doses among  
teen’s true state of residence n= 14460(those with responses of Don’t Know and unknown were removed from the calculation of this value).All values in table are statistically significant 
with p-value = 0.0003. 
 
Table 2 provides demographic characteristics of adolescents 13 to 17 years of age who either 
had received a dose of HPV vaccine or who had not started the series. There was statistically 
significant difference found between those having received a dose of the HPV vaccine and 
those who had not for seven of the sociodemographic factors selected.  Age of teen, gender of 
teen, relationship of respondent to teen, mother’s age, mother’s education level, and marital 
status of mother all had statistically significant p-values indicating a difference between those 
who had started HPV vaccination and those who had not. There is correlation between the 
selected sociodemographic factors and initiation of HPV vaccination.   
 
 
 
 
  
Table 2: Characteristics of NIS-Teen 2016 Respondents Residing in the South by Vaccination Status  
Participant Characteristics  n=14460 
Number(%) 
HPV Dose? 
Yes (%) 
HPV Dose?  
No (%) 
p-value ⱡ  
*Age of Teen    <.0001 
13 2927 (20.2) 1327 (45.3) 1600 (54.7)  
14 2872 (19.9) 1415 (49.3) 1457 (50.7)  
15 2932 (20.3) 1516 (51.7) 1416 (48.3)  
16 3060 (21.2) 1637 (53.5) 1423 (46.5)  
17 2669 (18.5) 1456 (54.6) 1213 (45.5)  
Gender of Teen    <.0001 
Male 7429 (51.4) 3390 (45.6) 4039 (54.4)  
Female 7031 (48.6) 3961 (56.3) 3070 (43.7)  
Race/Ethnicity of Teen    0.9211 
Hispanic 2579 (17.8) 1411 (54.7) 1168 (45.3)  
Non-Hispanic White Only 8063 (55.8) 3899 (48.4) 4164 (51.6)  
Non-Hispanic Black Only 2425 (16.8) 1328 (54.8) 1097 (45.2)  
Non-Hispanic Other + Multiple Race 1393 (9.6) 713 (51.2) 680 (48.8)  
Relationship of Respondent to Teen    0.0002 
Mother (step, foster, adoptive)/Female Guardian 9653 (66.8) 5169 (53.55) 4484 (46.5)  
Father (step, foster, adoptive)/Male Guardian 3662 (25.3) 1655 (45.19) 2007 (54.8)  
Grandparent 600 (4.2) 315 (52.50) 285 (47.5)  
Other Family Member/Friend 540 (3.7) 210 (38.89) 330 (61.1)  
Don’t Know 1 (0.0) -- 1 (100)  
Refused 4 (0.0) 2 (50.0) 2 (50.0)  
Mother’s Age Category    0.0205 
≤ 34 Years 1387 (9.6) 721 (52.0) 666 (48.0)  
34 to 44 Years 6249 (43.2) 3054 (48.9) 3195 (51.1)  
≥ 45 Years 6824 (47.2) 3576 (52.4) 3248 (47.6)  
Mother’s Education Level    0.0353 
Less than 12 Years 1529 (10.6) 791 (51.7) 738 (48.3)  
12 Years 2473 (17.1) 1203 (48.7) 1270 (51.4)  
More than 12 Years, Non-College Graduate 3758 (26.0) 1848 (49.2) 1910 (50.8)  
College Graduate 6700 (46.3) 3509 (52.4) 3191 (47.6)  
Mother’s Marital Status     <.0001 
Married 9914 (68.6) 4861(49.0) 5053 (51.0)  
Never Married/Widowed/Divorced/ 
Separated/Deceased/Living with Partner 
4546 (31.4) 2490 (54.8) 2056 (45.2)  
Housing     0.2441 
Owned or Being Bought 10345 (71.5) 5237 (50.6) 5108 (49.4)  
Rented 3602 (24.9) 1867 (51.8) 1735 (48.2)  
Other Arrangement 357 (2.5) 175 (49.0) 182 (51.0)  
Don’t Know 20 (0.1) 10 (50.0) 10 (50.0)  
Refused 136 (0.9) 62 (45.6) 74 (54.4)  
**Poverty Status     0.3758 
Above Poverty > $75,000 6431 (44.5) 3282 (51.0) 3149 (49.0)  
Above Poverty ≤ $75,000 4653 (32.2) 2256 (48.5) 2397 (51.5)  
Below Poverty 2432 (16.8) 1368 (56.3) 1064 (43.8)  
Unknown 944 (6.5) 445 (47.1) 499 (52.9)  
Number of Children under 18 in House Hold     0.3550 
One 5701 (39.4) 2815 (49.4) 2886 (50.6)  
Two or Three 7419 (51.3) 3903 (52.6) 3516 (47.4)  
Four or More 1340 (9.3) 633 (47.2) 707 (52.8)  
*Age of teen at time of interview 
** Based on the 2015 census poverty threshold; based on exact income if given or any established income bound 
ⱡ Mantel-Haenszel Chi-square test was used to calculate p-values using 95 % confidence interval (CI) for the association between teen’s sociodemographic factors and the difference of answering 
yes or no to having any doses of HPV. n= 14460(those with responses of Don’t Know and unknown were removed from the calculation of this value). 
 4.2 Distribution of Reasons for Not Vaccinating for HPV 
 
 Frequency distributions for the 12 reasons for not vaccinating for HPV can be found in 
Figure 1. The distribution of reasons for not vaccinating ranged from 0.4% citing 
“religion/orthodox” to 20.7% citing “vaccine as not needed/not necessary” among those with 
no intention to vaccinate for HPV. The top four reasons for not vaccinating for HPV were: 
vaccine not needed/not necessary (20.7%), not recommended (16.7%), safety concerns/side 
effects (16.2%) and lack of knowledge (12.3%).  
  Figure 1: Distribution of Reasons for not Vaccinating Among Those not Intending to Vaccinate (n=5824) 
 
 
4.3 Top Four Reasons for Not Vaccinating for HPV 
 
The distribution of sociodemographic information for the top four reasons for not 
vaccinating for HPV vaccine highlight interesting trends. Figures 2 through 5 show the 
distribution of the top four reasons by different sociodemographic factors. Those who 
answered “yes” for the top four reasons were divided out by gender of teen and age of mother. 
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 Approximately over 80% of those electing not to vaccinate because of the top four reasons had 
mothers over the age of 34. Less than 15% of the respondents electing not to vaccination due 
to the top four reasons had mothers who were 34 years old or younger. This was the case for 
both male and female teens. Those declining to vaccinate for HPV due to the top four reasons 
tend to be teens with older mothers.  
    Figure 2: Reasons for not Vaccinating by age of Mother for Male Teens 
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 Figure 3: Reasons for Not Vaccinating by Age of Mother for Female Teens 
 
 
Mothers tended to be 45 years or older for those choosing not to vaccinate for HPV because 
“vaccine was not needed/not necessary” or because “vaccine was not recommended”. A 
slightly larger percentage of those not vaccinating because of “safety concerns/side effects” or 
“lack of knowledge” had mothers between the ages of 35 to 44. Those who declined HPV 
vaccination were likely to be teenagers with older mothers. This finding aligns with what was 
found in the literature; mothers of teens not vaccinated for HPV tend to be older.  
 Figure 4 shows the top four reasons given for not vaccinating by the relationship of the 
respondent to the teen. More mothers/female guardians responded with the top four reasons 
for not vaccinating their teen for HPV. 75.4% of those who responded that “safety 
concerns/side effects” were the main reason for not vaccinating for HPV were mothers/female 
guardians of teen.  
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            Figure 4: Reasons for Not Vaccinating for HPV by Respondent’s Relation to the Teen 
 
 
Among those who selected “vaccine not recommended” as the reason for not vaccinating for 
HPV, 37.9% were fathers/male guardians. Figure 5 shows the breakdown of those who 
answered with the top four reasons by the number of teens under 18 in the household. 
     Figure 5: Number of Teens Under 18 in Household by Top Four Reasons for Not Vaccinating  
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 The smallest proportion of those not vaccinating due to the top four reasons had households 
with 4 or more teens under 18. The bulk of those responding with the top four reasons for not 
vaccinating for HPV had households with 2 or 3 teens under the age of 18. Among those who 
said they would not vaccinate for HPV because it was “not needed/not necessary”, 51.6% had 
households with 2 or 3 children under the age of 18. 47% of those who elected to not vaccinate 
for HPV because the vaccine was not recommended had households with 2 or 3 children under 
the age of 18. For those who did not vaccinate because of “safety concerns/side effects” or 
because of “lack of knowledge”, 50.3% and 49.4% respectively, were families with 2 or 3 
children under the age of 18 in the household. This may indicate that the number of children 
under 18 in the household may impact the decision to vaccinate for HPV. It’s conceivable that 
that parents with more children may have had more exposure to recommendations for HPV 
vaccination due to more encounters with healthcare professionals.  
4.4 Sociodemographic Factors & Top Four Reasons for Not Vaccinating for HPV 
 
 All odds ratio estimates for sociodemographic factors tested for association with top 
four reasons for not vaccinating in the model can be found in the appendix. Table 3 has all the 
statistically significant sociodemographic factors associated with the top four reasons for not 
vaccinating in the South. 
 
 
 
 
 
 Table 3:  Characteristics Associated with Top Reasons for not Vaccinating  
Reasons for Not Vaccinating for HPV   
 Point 
Estimate  
95% Wald Confidence Limits  
Characteristics for “Not needed/Not necessary”    
              Mom’s age between 35 - 44 0.74 0.57 - 0.96 
              Relation of Respondent to teen being mother/female guardian 0.83 0.72 - 0.97 
Characteristics for “Vaccine not recommended”    
              Gender of Teen Being Male 1.21 1.03 - 1.42 
              Mother having more than 12 yrs non-college education  0.80 0.65 - 0.98 
              Mother being a college graduate 0.63 0.52 - 0.76 
              Relation of respondent to teen being mother/female guardian 0.65 0.55 - 0.76 
Characteristics for “Safety Concerns/Side Effect”    
              Gender of Teen Being Male 0.64 0.55 - 0.74 
              Mother having more than 12 yrs non-college education 1.39 1.11 - 1.74 
              Mother being a college graduate 1.45 1.17 - 1.79 
              Relation of respondent to teen being mother/female guardian 2.05 1.70 - 2.46 
              Race Being White 1.49 1.19 - 1.86 
Characteristics for “Lack of Knowledge”     
              Gender of Teen Being Male 1.39 1.16 - 1.67 
              Mother having more than 12 yrs non-college education 0.79 0.56 - 0.89 
              Mother being a college graduate 0.57 0.46 - 0.71 
              Only one child <18 yrs in household  1.87 1.29 - 2.72 
              Two or three children <18 yrs in household  1.70 1.19 - 2.43 
              Relation of respondent to teen being mother/female guardian 0.83 0.69 - 0.99 
*All odds ratios on this table were statistically significant.    
 Several sociodemographic factors were found to be statistically significant in influencing 
the decision to not vaccinate because of the reason “vaccine is not needed or not necessary”. 
Mothers between the ages of 35 to 44 were 26% less likely to answer that the main reason for 
not vaccinating was because HPV vaccine was “not needed/not necessary” when compared to 
mothers who were 34 years old or younger. Mothers or female guardians were 17% less likely 
to decline HPV vaccination because it was “not needed/not necessary” when compared with 
fathers or male guardians.  
 Factors in the model that were found to be statistically significant with answering that 
“vaccine not recommended” was the main reason for declining HPV vaccination were: the 
gender of the teen being male, the relation the respondent to teen being mother/female 
guardian, the mother having higher than 12 years non-college education, and the mother 
having college education. Those who were male teens were 21% more likely to not vaccinate 
 for HPV because vaccine was not recommended when compared to female teens. Teens whose 
mothers had 12 years or more non-college education were 20% less likely to indicate that the 
reason for not vaccinating for HPV was “vaccine not recommended” when compared with teens 
whose mothers had high school or lower level education. Teens with mothers who were college 
graduates were 37% less likely to say they did not vaccinate for HPV because it was “not 
recommended” when compared with teens whose mothers had a high school or lower level 
education. Teens whose mothers had higher education levels were less likely to have provided 
the reason, “vaccine not recommended”, as the main reason for not vaccinating for HPV. 
Mohammed et al. (2016) also found that teens with mothers who had lower education levels 
received the lowest recommendation rates for HPV. The literature supports what was found in 
this model.  Mothers or female guardians were 35% less likely to say the main reason for not 
vaccinating was “vaccine not recommended” when compared to fathers or male guardians. This 
indicates that fathers or male guardians are not vaccinating their teens because vaccines are 
not being recommended to them.  
 For individuals who answered that the main reason for not vaccinating for HPV was 
because of “safety concerns/side effects”, the following factors were found to be statistically 
significant with this response: gender of the teen being male, mother having 12 years or more 
non-college education, mother being a college graduate, respondent being the mother or 
female guardian of the teen, and race of teen being white. Male teens were 37% less likely than 
female teens to indicate that “safety concerns/side effects” were the main reasons for not 
vaccinating. Teens with mothers who had more than 12 years non-college education were 39% 
more likely to indicate that safety concerns or side effects were the main reason for not 
 vaccinating for HPV when compared with teens whose mothers had high school or lower level 
education. Teens with mothers who were college graduates were 45% more likely to indicate 
that HPV vaccine was declined because of “safety concerns/side effects”.  Mothers or female 
guardians were 2.05 times more likely to indicate “safety concerns/side effects” were the main 
reason for not vaccinating when compared to fathers or male guardians. White teens were 49% 
more likely to say, “safety concerns/side effects” were the main reason for not vaccinating 
when compared with black teens. The education level of the mother shows up again with this 
reason and teens whose mothers have higher education were more likely to indicate “safety 
concerns/side effects” as the main reason for not vaccinating their teen for HPV.    
 For respondents who answered that the main reason for not vaccinating for HPV was 
due to “lack of knowledge”, the following factors were found to be statistically significant: 
gender of teen being male, mother having more than 12 years non-college education, mother 
being a college graduate, only having one child under 18 in the household, having 2 or 3 
children under 18 in the household, and the respondent being the mother or female guardian 
to the teen. Male teens were 39% more likely to have “lack of knowledge” be the reason that 
was given for not vaccinating when compared to female teens. Teens whose mother had more 
than 12 years non-college education were 21% less likely to indicate that lack of knowledge was 
the reason for not vaccinating for HPV. Meanwhile teens with mothers with college education 
were 43% less likely to indicate lack of knowledge as a reason for not vaccinating for HPV when 
compared to mothers with high school or lower level of education. Teens in households with 
only one child under 18 were 87% more likely to indicate lack of knowledge as the reason for 
not vaccinating when compared with households with 4 or more children under the age of 18. 
 Families with 2 or 3 children under 18 were 70% more likely to indicate lack of knowledge was 
the main reason for not vaccinating when compared with families with 4 or more children 
under 18. Mothers or female guardians were 18% less likely to say lack of knowledge was the 
main reason for not vaccinating when compared to fathers or male guardians. These findings 
indicate that mother’s higher education level was a protective factor against selecting lack of 
knowledge as the reason for not vaccinating. Smaller household size seems to indicate a higher 
chance of not vaccinating for HPV because of lack of knowledge.  
 All four reasons for choosing not to vaccinate for HPV had some statistically significant 
finding for the respondent being the mother/female guardian of the teen. This indicates that 
the relationship of the respondent to teen has some influence on choosing not to vaccinate for 
HPV due to the top four reasons. In three of the top four reasons, there was consistent 
statistical significance among these factors: mother’s education level being higher than high 
school and gender of the teen. Household size was only found to be statistically significant for 
the response of “lack of knowledge” as the reason for not vaccinating. Households with one, 
two or three children under the age of 18 were more likely to cite lack of knowledge as the 
main reason for not vaccinating for HPV. 
Discussion 
5.1 Discussion & Limitations 
 
 The findings in this study echo previous published literature. Teens in the south are not 
vaccinating for many of the same reasons found by researchers looking at national data. The 
respondent being the mother or female guardian was found to be statistically significant for the 
top four reasons for not vaccinating. This is worth noting because mothers/female guardians 
 serve as the influential decisionmakers regarding their teens receiving HPV vaccination. 
Because mothers/female guardians are sort of gatekeepers for their teens it is important to 
address the concerns that they are most worried about. Mothers were also 2.05 times more 
likely to indicate, “safety concerns/side effects” as the main reason for not vaccinating. If 
mothers are making the decisions about vaccinations for HPV then their major concerns need 
to be successfully addressed by public health officials. Gender of the teen is also an important 
factor to keep in mind when evaluating the reasons for not vaccinating. Male teens were 20% 
more likely to not vaccinate because vaccine was not recommended and 39% more likely to not 
vaccinate because of lack of knowledge.  Having a mother with higher education means that 
“safety concerns/side effects” are main reasons for not vaccinating for HPV. In contrast having 
a mother with a high school level or lower education means the reason for not vaccinating is 
due to lack of vaccine recommendation and lack of knowledge.  This finding is in alignment with 
what was found in previous research and shows that those electing not to vaccinate for HPV 
tend to be mothers with higher education. Another important finding is that those with higher 
education did not cite lack of knowledge as a reason, instead they were less likely to indicate 
not vaccinating because of lack of knowledge.  Mothers with higher education had safety 
concerns but still did not indicated they have lack of knowledge about HPV vaccines. Future 
research efforts should consider exploring the rational for the concern about safety/side effects 
for HPV vaccination among mothers with higher education. Further investigation is warranted 
for understanding what “lack of knowledge” means to parents. Does it mean they have no idea 
what HPV vaccines are meant to protect their child from? Or is it that they have heard of the 
vaccine but would like more information? These and similar questions should be explored for 
 those who indicated “lack of knowledge” was the main reason for not vaccinating for HPV.  
Additional research should focus on those who are not vaccinating and attempt to identify best 
methods to address concerns for these populations.  
 Limitations of this study include the inability to generalize any of these findings beyond 
the region that was studied. Because the NIS-Teen data is a cross-sectional survey it is not 
generalizable over different periods of time. Household surveys may include recall bias because 
respondents were asked questions about events in the past (has the teen ever received HPV 
vaccination). Those who refused to respond to the questions were not included in the analysis 
and there could be something unique about those that refused that could have influenced their 
decisions about HPV vaccines. Future efforts should consider looking at those who refused the 
questions about vaccinating for HPV and compare them with the group that did respond to see 
if variances among the groups exist. Differences in attitudes towards HPV vaccination by states, 
by different health departments and by providers can influence decisions parents make to 
vaccinate for HPV. This, in turn, can be a confounding variable impacting findings in this study. 
The variables available in the NIS-Teen 2016 dataset do not account for these other potentially 
influential factors. The overall burden of disease for HPV in the population may be understated 
as most cases are latent.   
5.2 Implications of Findings & Recommendations  
 
 Public health efforts around HPV vaccination and education should focus on mothers 
with higher education levels. In addition, the interventions should be centered around 
educating mothers about the safety of the HPV vaccine. Mothers with less than high school 
education should also be targeted with public health efforts to improve knowledge about HPV 
 vaccination. Providers should be educated about the importance of making consistent 
recommendations for all their clients and follow all ACIP guidelines. Providers need to 
recommend HPV vaccination for mothers with less than high school education and boys more 
consistently. The public has a limited understanding of how the human immune system works 
and the ways in which vaccines interact with the natural immune response to induce protection 
against vaccine preventable diseases. HPV vaccine education should focus on efforts to alleviate 
the concerns about safety and side effects. Education efforts need to be targeted to those who 
are not vaccinating. Providers need to be educated on how to: 1) address concerns from 
parents about safety/side effects, 2) handle resistance from parents who feel vaccinating for 
HPV is not need or not necessary, 3) make consistent recommendations across all patient 
populations, and provide resources for those who lack knowledge. Public health must also 
support the efforts of providers by disseminating accurate and timely information about the 
need to vaccinate every child with HPV vaccine.    
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 Appendix 
 
Table 4: Odds Ratio Estimates for Reason “Not Needed/Not Necessary” 
Sociodemograpic Factor  Point Estimate 95% Wald Confidence Limits  
Gender of Teen    
      Female  1.0 -- 
      Male 1.12 0.97 - 1.29 
Mother’s Age    
      ≤34 Years 1.0 -- 
      35 – 44 Years  0.74 0.57 - 0.96 
      ≥45 Years  0.80 0.61- 1.05 
Mother’s Education Level    
      ≤ high school 1.0 -- 
      >12 yrs non-college  1.21 0.99 - 1.47 
      College graduate 1.16 0.96 - 1.39 
Number of Children <18 Years in Household    
      4 or more 1.0 -- 
      One only  1.0 0.77 - 1.30 
      Two or three 1.11 0.87 - 1.41 
Relationship of Respondent to Teen    
      Father/male guardian 1.0 -- 
      Mother/female guardian 0.83 0.72 - 0.97 
Race/Ethnicity of Teen    
      Black  1.0 -- 
      White 0.93 0.77 - 1.12 
      Hispanic  0.79 0.61 - 1.01 
Table includes reference groups (1.0) for each sociodemogrpahic factor included in the model. Bolded values indlicate statistical significance.  
 
 
Table 5: Odds Ratio Estimates for Reason “[Vaccine] Not Recommended” 
Sociodemograpic Factor  Point Estimate 95% Wald Confidence Limits  
Gender of Teen    
      Female 1.0 -- 
      Male 1.21 1.03 - 1.42 
Mother’s Age     
      ≤34 Years  1.0 -- 
      35 – 44 Years  1.17 0.86 - 1.59 
      ≥45 Years  1.33 0.96 - 1.82 
Mother’s Education Level    
      ≤ high school 1.0 -- 
      >12 yrs non-college  0.80 0.65 - 0.98 
      College graduate 0.63 0.52 - 0.76 
Number of children <18 Years in Household    
      4 or more 1.0 -- 
      One only   0.87 0.66 - 1.15 
      Two or three  0.87 0.67 - 1.13 
Relationship of Respondent to Teen    
      Father/male guardian 1.0 -- 
      Mother/female guardian 0.65 0.55 - 0.76 
Race/Ethnicity of Teen    
      Black  1.0 -- 
      White 0.85 0.68 - 1.05 
      Hispanic  1.00 0.77 - 1.31 
Table includes reference groups (1.0) for each sociodemogrpahic factor included in the model. Bolded values indlicate statistical significance. 
 
 
 
  
Table 6: Odds Ratio Estimates for Reason “Safety Concerns/Side Effects” 
Sociodemograpic Factor  Point Estimate 95% Wald Confidence Limits 
Gender of Teen    
      Female 1.0 -- 
      Male 0.64 0.55 - 0.74 
Mother’s Age    
      ≤34 Years 1.0 -- 
      35 – 44 Years  1.31 0.95 - 1.81 
      ≥45 Years  1.07 0.77 - 1.50 
Mother’s Education Level    
      ≤ high school 1.0 -- 
      >12 yrs non-college  1.39 1.11 - 1.74 
      College graduate 1.45 1.17 - 1.79 
Number of children <18 Years in houshold    
      4 or more 1.0 -- 
      One only 0.86 0.65 - 1.13 
      Two or three 0.87 0.68 - 1.13 
Relationship of respondent to teen    
      Father/male guardian 1.0 -- 
      Mother/female guardian 2.05 1.70 - 2.46 
Race/Ethnicity of teen    
      Black 1.0 -- 
      White 1.49 1.19 - 1.86 
      Hispanic  0.86 0.65 - 1.18 
Table includes reference groups (1.0) for each sociodemogrpahic factor included in the model. Bolded values indlicate statistical significance.  
 
 
Table 7: Odds Ratio Estimates for Reason “Lack of Knowledge” 
Sociodemograpic Factor  Point Estimate 95% Wald Confidence Limits 
Gender of Teen    
      Female 1.0 -- 
      Male 1.39 1.16 - 1.67 
Mother’s Age    
      ≤34 Years  1.0 --- 
      35 – 44 Years  0.98 0.71 - 1.37 
      ≥45 Years  0.84 0.60 - 1.20 
Mother’s Education Level    
      ≤ high school  1.0 -- 
      >12 years non-college  0.71 0.56 - 0.89 
      College graduate 0.57 0.46 - 0.71 
Number of children <18 Years in houshold    
      4 or more  1.0 -- 
      One only  1.87 1.29 - 2.72 
      Two or three 1.70 1.19 - 2.43 
Relationship of respondent to teen    
      Father/male guardian 1.0 -- 
      Mother/female guardian 0.828 0.69 - 0.99 
Race/Ethnicity of Teen    
      Black  1.0 -- 
      White 0.81 0.64 - 1.03 
      Hispanic  0.99 0.74 - 1.33 
Table includes reference groups (1.0) for each sociodemogrpahic factor included in the model. Bolded values indlicate statistical significance.  
 
